tiprankstipranks
Advertisement
Advertisement

Bath & Body Works Reports Q4 Results, Guides 2026 Lower

Story Highlights
  • Bath & Body Works’ fourth-quarter and full-year 2025 sales were flat to slightly down, while earnings declined despite share repurchases and transformation costs.
  • The company beat its fourth-quarter guidance but forecasts lower adjusted earnings and a sales decline in 2026 as it pushes a major business transformation and brand repositioning.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Bath & Body Works Reports Q4 Results, Guides 2026 Lower

Claim 55% Off TipRanks

Bath & Body Works ( (BBWI) ) has issued an update.

Bath & Body Works reported on March 4, 2026 that fourth-quarter 2025 net sales fell 2% to $2.7 billion, with earnings per diluted share declining to $1.99, or $2.05 on an adjusted basis, as it absorbed $15 million in transformation-related costs. Full-year 2025 net sales were essentially flat at $7.3 billion, but earnings per share dropped to $3.11, or $3.21 adjusted, while the company repurchased 15.1 million shares for $400 million.

Management said fourth-quarter results came in above guidance and highlighted early progress on its “Consumer First Formula,” including accelerated innovation in core categories, brand refresh efforts, an earlier-than-planned Amazon launch and a streamlined operating model. Despite this, Bath & Body Works guided to a 2.5% to 4.5% net sales decline for fiscal 2026 and lower adjusted earnings, reflecting ongoing business transformation, though headline EPS is expected to benefit from litigation-related gains, tax items and bond-related impacts, alongside projected free cash flow of about $600 million and interest savings from redeeming remaining 2027 bonds.

The most recent analyst rating on (BBWI) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.

Spark’s Take on BBWI Stock

According to Spark, TipRanks’ AI Analyst, BBWI is a Neutral.

The score is held back primarily by financial risk: declining revenue/profitability and a highly concerning balance sheet with negative equity. Valuation is a meaningful positive (low P/E and solid yield), while technicals and the earnings call indicate mixed-to-weak near-term conditions tempered by cost-savings and channel expansion initiatives. The note redemption is a modest additional positive for improving debt profile.

To see Spark’s full report on BBWI stock, click here.

More about Bath & Body Works

Bath & Body Works, Inc. is a global personal care and home fragrance retailer, known for its scented body care products and 3‑wick candles that deliver a luxury fragrance experience. The company serves consumers through more than 1,900 stores in the U.S. and Canada, over 500 international locations, its e‑commerce platform and, more recently, distribution on Amazon.

Its product lineup spans fine fragrance mists, body creams, lotions, eau de parfum, body wash, hand soap, sanitizers and other formats formulated with selected ingredients. The brand focuses on making its stores and online channels easy to shop while leveraging its iconic scents to reinforce its positioning as a leading global fragrance-driven lifestyle brand.

Average Trading Volume: 5,431,586

Technical Sentiment Signal: Sell

Current Market Cap: $4.51B

See more data about BBWI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1